Evidence map›Paper›PMID 34481493›Full record

ArticleOrphanet journal of rare diseases2021

The de novo FAIRification process of a registry for vascular anomalies.

Karlijn H J Groenen, Annika Jacobsen, Martijn G Kersloot, Bruna Dos Santos Vieira, Esther van Enckevort, Rajaram Kaliyaperumal, Derk L Arts, Peter A C 't Hoen, Ronald Cornet, Marco Roos and 1 more

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Karlijn H J Groenen *Department of Medical Imaging, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. Karlijn.Groenen@radboudumc.nl.ORCID 0000-0003-2055-2665
Annika Jacobsen *Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0003-4818-2360
Martijn G KerslootDepartment of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0003-3357-3027
Bruna Dos Santos VieiraDepartment of Medical Imaging, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0001-7893-0505
Esther van EnckevortUniversity Medical Center Groningen, Department of Genetics and Genomic Coordination Center, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-2440-3993
Rajaram KaliyaperumalDepartment of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-1215-167X
Derk L ArtsCastor EDC, Amsterdam, The Netherlands.ORCID 0000-0001-5702-5856
Peter A C 't HoenCenter for Molecular and Biomolecular Informatics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0003-4450-3112
Ronald CornetDepartment of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-1704-5980
Marco Roos *Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-8691-772X
Leo Schultze Kool *Department of Medical Imaging, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0001-9217-278X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPatient data registries that are FAIR-Findable, Accessible, Interoperable, and Reusable for humans and computers-facilitate research across multiple resources. This is particularly relevant to rare diseases, where data often are scarce and scattered. Specific research questions can be asked across FAIR rare disease registries and other FAIR resources without physically combining the data. Further, FAIR implies well-defined, transparent access conditions, which supports making sensitive data as open as possible and as closed as necessary.

resultsWe successfully developed and implemented a process of making a rare disease registry for vascular anomalies FAIR from its conception-de novo. Here, we describe the five phases of this process in detail: (i) pre-FAIRification, (ii) facilitating FAIRification, (iii) data collection, (iv) generating FAIR data in real-time, and (v) using FAIR data. This includes the creation of an electronic case report form and a semantic data model of the elements to be collected (in this case: the "Set of Common Data Elements for Rare Disease Registration" released by the European Commission), and the technical implementation of automatic, real-time data FAIRification in an Electronic Data Capture system. Further, we describe how we contribute to the four facets of FAIR, and how our FAIRification process can be reused by other registries.

conclusionsIn conclusion, a detailed de novo FAIRification process of a registry for vascular anomalies is described. To a large extent, the process may be reused by other rare disease registries, and we envision this work to be a substantial contribution to an ecosystem of FAIR rare disease resources.

Indexed as

EcosystemRare DiseasesHumansRegistriesFAIR dataFAIRification processInteroperabilityPatient registryRare diseasesVascular anomalies

Identifiers

PMID34481493
PMCPMC8418729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.